Alternative macrophage activation limits immunopathology
巨噬细胞的替代激活限制了免疫病理学
基本信息
- 批准号:9216075
- 负责人:
- 金额:$ 31.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-09-30 至 2019-03-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAgonistAlveolarBiological AssayBiologyBloodBone MarrowCause of DeathCd68CellsChestChronicChronic lung diseaseCoculture TechniquesDataDiseaseEpithelialEpithelial CellsGasesGeneticGoalsGrowthHealthHelminthsHomeostasisHookworm InfectionsHost DefenseImageImmunityImmunoglobulin GImmunosuppressionImmunosuppressive AgentsIndividualInfectionInflammationInflammatoryInfluenzaInterleukin-10Interleukin-4KidneyLifeLiverLungLung InflammationLung diseasesLymphocyteLymphoidLymphoid CellMacrophage ActivationMediatingMediator of activation proteinMicrobeMolecularMonitorMusMyelogenousNatural regenerationNatureOxygenPhagocytesPopulationProcessProductionProteinsPulmonary Gas ExchangePulmonary InflammationRecruitment ActivityRegulatory T-LymphocyteReportingResolutionRespiratory physiologyRoleStructure of parenchyma of lungT-Lymphocyte SubsetsTestingTissuesTransforming Growth Factor betaUnited StatesWnt proteinsWorkWound Healingairway epitheliumcytokineimmunopathologyimmunoregulationinjuredkillingslung injurylung repairmacrophagemonocytenovelpathogenpreventpulmonary functionrepairedrestorationtissue regenerationtissue repairtooltumor
项目摘要
DESCRIPTION (provided by applicant): Macrophages are heterogeneous myeloid phagocytes that drive host defense and wound repair through unresolved mechanisms. This project investigates lung macrophage biology in the context of host immunity and tissue repair following parasitic helminth infection. More than one billion people worldwide are infected with parasitic helminthes and depending upon the worm species, infected individuals can suffer various degrees of lung injury. Historical data from chest x-ray images of worm-infected individuals revealed spontaneous resolution of tissue damage occurred following anti-helminthic therapy. Our data shows that lung macrophages are essential for the transient nature of helminth induced lung injury. This renewal application will establish the mechanism(s) used by lung macrophages to suppress pathogen-specific inflammation, facilitate re- epithelialization and restore lung gas exchange function. We will genetically deplete CD68+ tissue macrophages, monitor blood oxygen content (SpO2), and track both pro-inflammatory group 2 innate lymphoid cells (ILC2) and immunosuppressive regulatory T cell populations to achieve our project goals. We have evidence that lung macrophage depletion causes increased expansion of ILC2 and reduces interleukin 10 levels within injured lung tissue. Moreover, we provide evidence that macrophages drive re-epithelialization through producing Wnt proteins, which are established mediators of epithelial cell regeneration. Therefore, our project investigates mechanisms of host protective immunity during hookworm infection as a surrogate for understanding reversible lung injury. A clearer understanding of lung repair following infection is extremely important for millions of individuals suffering from acute and chronic forms of lung disease. Combined, acute and chronic lung diseases are predicted to be the 3rd leading cause of death within the United States by 2020. Clearly, there is a great need for understanding how inflammation and repair are regulated within the pulmonary tract. Therefore, we will test the hypothesis that lung macrophages produce immunosuppressive cytokines that limit ILC2 expansion and promote regulatory T cell expansion and also that lung macrophages directly promote epithelial regeneration via a Wnt4a-dependent mechanism. This hypothesis will be tested in the following specific aims: Aim 1 will determine whether repair of pulmonary function and restoration of lung homeostasis requires lung macrophages or ILC2. Aim 2 will determine whether lung macrophages suppress ILC2 or induce regulatory T cell expansion via IL-10 and/or TGF-dependent mechanisms and Aim 3 will identify the molecular mechanism(s) responsible for macrophage-driven epithelial regeneration. Completion of this work will provide a deeper understanding of how infection-induced inflammation and pulmonary tissue regeneration are orchestrated via myeloid and lymphoid lineages.
描述(由申请人提供):巨噬细胞是异质性骨髓吞噬细胞,通过未解决的机制驱动宿主防御和伤口修复。本计画探讨肺部巨噬细胞生物学在寄生虫感染后的宿主免疫与组织修复的情形。全世界有超过10亿人感染寄生蠕虫,根据蠕虫的种类,感染者可能遭受不同程度的肺损伤。蠕虫感染个体的胸部X射线图像的历史数据显示,抗蠕虫治疗后组织损伤自发消退。我们的数据表明,肺巨噬细胞是必不可少的短暂性蠕虫引起的肺损伤。本次更新申请将确立肺巨噬细胞用于抑制病原体特异性炎症、促进上皮再形成和恢复肺气体交换功能的机制。我们将从基因上耗尽CD 68+组织巨噬细胞,监测血氧含量(SpO 2),并跟踪促炎性第2组先天淋巴细胞(ILC 2)和免疫抑制调节性T细胞群,以实现我们的项目目标。我们有证据表明,肺巨噬细胞的消耗会导致ILC 2的扩张增加,并降低受伤肺组织中白细胞介素10的水平。此外,我们提供了巨噬细胞通过产生Wnt蛋白驱动上皮再形成的证据,Wnt蛋白是上皮细胞再生的既定介质。因此,我们的项目研究钩虫感染期间宿主保护性免疫的机制,作为了解可逆性肺损伤的替代。更清楚地了解感染后的肺修复对于数百万患有急性和慢性肺部疾病的人来说非常重要。到2020年,急性和慢性肺部疾病预计将成为美国第三大死亡原因。显然,非常需要了解炎症和修复是如何在肺道内调节的。因此,我们将测试肺巨噬细胞产生限制ILC 2扩增并促进调节性T细胞扩增的免疫抑制性细胞因子以及肺巨噬细胞通过Wnt 4a依赖性机制直接促进上皮再生的假设。该假设将在以下具体目标中进行测试:目标1将确定肺功能的修复和肺稳态的恢复是否需要肺巨噬细胞或ILC 2。目的2将确定肺巨噬细胞是否通过IL-10和/或TGF依赖性机制抑制ILC 2或诱导调节性T细胞扩增,目的3将鉴定负责巨噬细胞驱动的上皮再生的分子机制。这项工作的完成将提供一个更深入的了解感染诱导的炎症和肺组织再生是如何通过骨髓和淋巴谱系编排。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
De'Broski R Herbert其他文献
De'Broski R Herbert的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('De'Broski R Herbert', 18)}}的其他基金
Central role for skin sensory neurons in anti-helminth immunity
皮肤感觉神经元在抗蠕虫免疫中的核心作用
- 批准号:
10665391 - 财政年份:2023
- 资助金额:
$ 31.75万 - 项目类别:
Neuronal regulation of sinonasal Type 2 inflammation
鼻窦 2 型炎症的神经元调节
- 批准号:
10740468 - 财政年份:2023
- 资助金额:
$ 31.75万 - 项目类别:
Myeloid derived IL-33 controls Treg responses during parasite infection
骨髓源性 IL-33 控制寄生虫感染期间的 Treg 反应
- 批准号:
10463791 - 财政年份:2021
- 资助金额:
$ 31.75万 - 项目类别:
Myeloid derived IL-33 controls Treg responses during parasite infection
骨髓源性 IL-33 控制寄生虫感染期间的 Treg 反应
- 批准号:
10317582 - 财政年份:2021
- 资助金额:
$ 31.75万 - 项目类别:
Perforin 2 controls unconventional cytokine release from mucosal APC
穿孔素 2 控制粘膜 APC 的非常规细胞因子释放
- 批准号:
10629434 - 财政年份:2021
- 资助金额:
$ 31.75万 - 项目类别:
Perforin 2 controls unconventional cytokine release from mucosal APC
穿孔素 2 控制粘膜 APC 的非常规细胞因子释放
- 批准号:
10283046 - 财政年份:2021
- 资助金额:
$ 31.75万 - 项目类别:
Myeloid derived IL-33 controls Treg responses during parasite infection
骨髓源性 IL-33 控制寄生虫感染期间的 Treg 反应
- 批准号:
10662289 - 财政年份:2021
- 资助金额:
$ 31.75万 - 项目类别:
Perforin 2 controls unconventional cytokine release from mucosal APC
穿孔素 2 控制粘膜 APC 的非常规细胞因子释放
- 批准号:
10472644 - 财政年份:2021
- 资助金额:
$ 31.75万 - 项目类别:
Trefoil factor proteins regulate inflammation and immunity
三叶因子蛋白调节炎症和免疫
- 批准号:
10179207 - 财政年份:2020
- 资助金额:
$ 31.75万 - 项目类别:
Physiological roles of schistosome TRP ion channels with atypical pharmacology
血吸虫 TRP 离子通道的生理作用与非典型药理学
- 批准号:
10078843 - 财政年份:2017
- 资助金额:
$ 31.75万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 31.75万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 31.75万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 31.75万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 31.75万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 31.75万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 31.75万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 31.75万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 31.75万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 31.75万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 31.75万 - 项目类别:
Grant-in-Aid for Scientific Research (C)